Disruption of cancer cell functions by task-specific drug perturbations

Mahmoud Ahmed1, Deok Ryong Kim1

  • 1Department of Biochemistry and Convergence Medical Science, Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, South Korea.

Insights

Cancer cells specialize in specific tasks, making them vulnerable to drugs targeting these functions. This study reveals that gene expression patterns predict drug sensitivity in specialized cancer cells.

Area of Science:

  • Cancer Biology
  • Genomics
  • Pharmacology

Background:

  • Cancer cells exhibit clonal expansion and functional specialization to gain a survival advantage.
  • Understanding the relationship between cancer cell specialization and drug response is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the hypothesis that cancer cells are vulnerable to drugs that disrupt their specialized functions.
  • To correlate gene expression profiles with drug perturbation responses in various cancer cell types.

Main Methods:

  • Analysis of gene expression data and drug response in cancer cells.
  • Clustering of cancer cells into archetypes based on gene expression patterns.
  • Enrichment analysis of cancer hallmark gene sets within cell archetypes and their drug responses.

Main Results:

  • Extremes in gene expression correlated with susceptibility to drug perturbations.
  • This correlation accurately predicted growth rate inhibition in breast cancer cells.
  • Distinct enrichment of cancer hallmarks in archetypes predicted cellular responses to drug perturbations.

Conclusions:

  • Specialized cancer cells demonstrate sensitivity to compounds that interfere with their specific tasks.
  • Gene expression and cancer hallmark enrichment serve as predictive biomarkers for drug sensitivity in cancer therapy.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K